Bioharvest Sciences Inc.
BHST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723464
No open-market purchases or sales by Bioharvest Sciences Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.80M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Bioharvest Sciences Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 20 | 19 | −1 |
| Shares | 1.70M | 1.68M | −18.3K (−1.1%) |
| Value | $7.38M | $4.80M | −$2.58M (−34.9%) |
New holders (2)
Institutions that held Bioharvest Sciences Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| K.J. Harrison & Partners Inc | 10,000 | $27.9K | 0.00% |
| Caitong International Asset Management Co., Ltd | 2 | $6 | 0.00% |
Sold out (3)
Institutions that held Bioharvest Sciences Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Jane Street Group, LLC | 13,083 | $56.8K |
| Vident Advisory, LLC | 11,576 | $50.2K |
| Federation des caisses Desjardins du Quebec | 76 | $325 |